Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012)
- PMID: 26232152
- PMCID: PMC4522101
- DOI: 10.1186/s13052-015-0160-4
Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012)
Abstract
Background: Intussusception is the most common cause of bowel obstruction in infants with an incidence ranging from 9-328 cases per 100,000 infants aged 0-11 months. Causes underlining this clinical manifestation are still unknown. Possible relationship with a withdrawn tetravalent rotavirus vaccine was not confirmed by post-licensure studies and actually no increased risk of intussusception was found between infants vaccinated with both the recently licensed rotavirus vaccines. Aim of this study is to analyze the intussusception hospitalizations in Sicily from 2003 to 2012 before the introduction of rotavirus universal vaccination and its possible relation with rotavirus gastroenteritis trend.
Methods: Were collected data from hospital discharge records occurred from 1(st) January 2003 to 31(st) December 2012 in Sicily. Intussusception cases were defined as all hospitalizations with an ICD-9-CM code of 560.0 on any discharge diagnoses. As a proxy for the severity of cases were considered ICD-9-CM procedure codes accounting for surgical or radiologic reduction.
Results: A total of 340 intussusception cases were hospitalized in Sicily from 2003 to 2012 in children aged 0-59 months. 46.8 % occurred in the age class 0-11 months. Hospitalization rate for intussusception was 11.4 cases per 100,000 per year (32.6 cases per 100,000 among 0-11 months children; 7.3 cases per 100,000 among 12-59 months children), with a M:F sex ratio of 1.8. During hospitalization only 25 % of intussusceptions had a spontaneous resolution, 56.5 % of cases required a surgical intervention. From 2003 to 2012 intussusception cases were equally distributed during the year without any seasonality, while gastroenteritis hospitalizations due to rotavirus infection have a typically late winter and spring distribution.
Conclusions: In Sicily from 2003 to 2012 hospitalizations due to intestinal invagination were higher among children aged 0-11 months with observed rates similar to other European countries. Regional baseline data analysis of intussusception among 0-59 children is recognized as an evidence-based public health strategy by international health authorities. Indeed, this strategy is necessary to compare any post-licensure age or sex-related change in intussusception trend after universal rotavirus vaccination introduction.
Figures
Similar articles
-
Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage.Hum Vaccin Immunother. 2018;14(9):2297-2302. doi: 10.1080/21645515.2018.1471306. Epub 2018 Jun 22. Hum Vaccin Immunother. 2018. PMID: 29757707 Free PMC article.
-
Unparalleled patterns of intussusception and rotavirus gastroenteritis hospitalization rates among children younger than six years in Italy.Ann Ig. 2017 Jan-Feb;29(1):38-45. doi: 10.7416/ai.2017.2130. Ann Ig. 2017. PMID: 28067936
-
Intussusception-associated hospitalization among Venezuelan infants during 1998 through 2001: anticipating rotavirus vaccines.Pediatr Infect Dis J. 2003 Mar;22(3):234-9. doi: 10.1097/01.inf.0000055064.76457.f3. Pediatr Infect Dis J. 2003. PMID: 12634584
-
Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines.Vaccine. 2015 Nov 27;33 Suppl 4:D55-9. doi: 10.1016/j.vaccine.2015.05.094. Epub 2015 Jun 27. Vaccine. 2015. PMID: 26122581 Review.
-
Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.Expert Rev Vaccines. 2014 Jan;13(1):43-57. doi: 10.1586/14760584.2014.861746. Epub 2013 Dec 4. Expert Rev Vaccines. 2014. PMID: 24308577 Review.
Cited by 7 articles
-
Rotavirus and the web: analysis of online conversations in Italy during 2020.Hum Vaccin Immunother. 2022 Dec 31;18(1):2002087. doi: 10.1080/21645515.2021.2002087. Epub 2021 Dec 2. Hum Vaccin Immunother. 2022. PMID: 34856884 Free PMC article.
-
Fourteen years' clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy.Hum Vaccin Immunother. 2021 Nov 2;17(11):4636-4645. doi: 10.1080/21645515.2021.1955611. Epub 2021 Aug 9. Hum Vaccin Immunother. 2021. PMID: 34370615 Free PMC article.
-
Update on the global epidemiology of intussusception: a systematic review of incidence rates, age distributions and case-fatality ratios among children aged <5 years, before the introduction of rotavirus vaccination.Int J Epidemiol. 2019 Aug 1;48(4):1316-1326. doi: 10.1093/ije/dyz028. Int J Epidemiol. 2019. PMID: 30879038 Free PMC article.
-
Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage.Hum Vaccin Immunother. 2018;14(9):2297-2302. doi: 10.1080/21645515.2018.1471306. Epub 2018 Jun 22. Hum Vaccin Immunother. 2018. PMID: 29757707 Free PMC article.
-
Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2 years of age in Nepal.Vaccine. 2018 Dec 14;36(51):7836-7840. doi: 10.1016/j.vaccine.2017.11.022. Epub 2017 Nov 21. Vaccine. 2018. PMID: 29169894 Free PMC article.
References
-
- Centers for Disease Control and Prevention (CDC) Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep. 1999;48(43):1007. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials